Despite lithium's postulated neuroprotective role [52], it also did not have a significant effect on plasma NfL nor GFAP, though it may have been underpowered considering that plasma NfL and GFAP levels were only mildly elevated in people with bipolar disorder. The gene discussed is NEFL; the disease is bipolar disorder.